Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell S Steiner

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
World Journal of Urology|May 21, 2003
High-grade prostatic intraepithelial neoplasia and prostate cancer risk reductionMitchell S Steiner
World Journal of Urology|June 26, 2003
We can really reduce the risk for prostate cancer?Mitchell S Steiner
World Journal of Urology|May 21, 2003
Antiestrogens and selective estrogen receptor modulators reduce prostate cancer riskMitchell S Steiner, Sharan Raghow
Clinical Prostate Cancer|March 30, 2004
Phase IIA clinical trial to test the efficacy and safety of Toremifene in men with high-grade prostatic intraepithelial neoplasiaMitchell S Steiner, Charlie R Pound
Surgical Oncology Clinics of North America|December 19, 2002
Prostate cancer gene therapyMitchell S Steiner, Jeffrey R Gingrich, Ravi D Chauhan
Cancer Research|March 13, 2002
Toremifene prevents prostate cancer in the transgenic adenocarcinoma of mouse prostate modelSharan Raghow, Massoumeh Z Hooshdaran, Sanjay Katiyar, et al.
Biochemical and Biophysical Research Communications|June 27, 2002
Cloning a cDNA encoding an alternatively spliced protein of BRCA2-associated factor 35Chiang Wang, Ida M McCarty, Louisa Balazs, et al.
Biochemical and Biophysical Research Communications|June 27, 2002
Immunohistological detection of BRAF25 in human prostate tumor and cancer specimensChiang Wang, Ida M McCarty, Louisa Balazs, et al.
Current Opinion in Supportive and Palliative Care|November 6, 2013
Selective androgen receptor modulators for the prevention and treatment of muscle wasting associated with cancerJames T Dalton, Ryan P Taylor, Michael L Mohler, et al.
Biochemical and Biophysical Research Communications|August 7, 2002
A prostate-derived cDNA that is mapped to human chromosome 19 encodes a novel proteinChiang Wang, Ida M McCarty, Louisa Balazs, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
World Journal of Urology|May 21, 2003
High-grade prostatic intraepithelial neoplasia and prostate cancer risk reductionMitchell S Steiner
World Journal of Urology|June 26, 2003
We can really reduce the risk for prostate cancer?Mitchell S Steiner
World Journal of Urology|May 21, 2003
Antiestrogens and selective estrogen receptor modulators reduce prostate cancer riskMitchell S Steiner, Sharan Raghow
Clinical Prostate Cancer|March 30, 2004
Phase IIA clinical trial to test the efficacy and safety of Toremifene in men with high-grade prostatic intraepithelial neoplasiaMitchell S Steiner, Charlie R Pound
Surgical Oncology Clinics of North America|December 19, 2002
Prostate cancer gene therapyMitchell S Steiner, Jeffrey R Gingrich, Ravi D Chauhan
Cancer Research|March 13, 2002
Toremifene prevents prostate cancer in the transgenic adenocarcinoma of mouse prostate modelSharan Raghow, Massoumeh Z Hooshdaran, Sanjay Katiyar, et al.
Biochemical and Biophysical Research Communications|June 27, 2002
Cloning a cDNA encoding an alternatively spliced protein of BRCA2-associated factor 35Chiang Wang, Ida M McCarty, Louisa Balazs, et al.
Biochemical and Biophysical Research Communications|June 27, 2002
Immunohistological detection of BRAF25 in human prostate tumor and cancer specimensChiang Wang, Ida M McCarty, Louisa Balazs, et al.
Current Opinion in Supportive and Palliative Care|November 6, 2013
Selective androgen receptor modulators for the prevention and treatment of muscle wasting associated with cancerJames T Dalton, Ryan P Taylor, Michael L Mohler, et al.
Biochemical and Biophysical Research Communications|August 7, 2002
A prostate-derived cDNA that is mapped to human chromosome 19 encodes a novel proteinChiang Wang, Ida M McCarty, Louisa Balazs, et al.
Pageof 3